Year: 2020
Type: article
Abstract: Severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) is the pathogen responsible of atypical pneumonia that has affected more than 330,000 people and caused death of more than 14,000 patients (as of March 23, 2020, WHO Report). Coronavirus spike (S) glycoproteins mediate entry into cells end predominantly lung epithelial alveolar cells precipitating an interstitial pneumonia that evolves through acute respiratory distress syndrome (ARDS) [1].
Source: Critical Care
Institutions: Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita, University of Bari Aldo Moro, University of Foggia, Ospedale San Bortolo, International Renal Research Institute of Vicenza
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,290
OpenAlex ID: W3016997471
